Will these three small caps benefit from change at the top?
Will these three small caps benefit from change at the top?
About this video
Key points:
Investors Mutual’s Marc Whittaker says CEO changes can materially alter the outlook for small-cap companies.
Integral Diagnostics is a key test of whether new management can deliver more consistent operating margins while Whittaker sees turnaround potential at Iress under new CEO Andrew Russell.
Automotive aftermarket group Bapcor could benefit from a fresh CEO and further cost reductions.
Investors Mutual’s Marc Whittaker says leadership changes can create significant catalysts for small-cap companies, with new management teams offering opportunities to improve margins, customer engagement and organic growth. Whittaker highlights Integral Diagnostics as a company where the incoming CEO faces a clear opportunity to improve operating-margin consistency. He says the company’s top line is growing around 6–8%, supported by indexation and scan volumes, but margins have fluctuated between 18% and 20%.
At Iress, Whittaker sees an opportunity for Andrew Russell to reconnect with customers, reinvest in the product and reduce costs. He points to Russell’s previous turnaround experience at Bravura and Class, saying Iress has a sticky customer base but has suffered from underinvestment and a lack of focus. Trading at around 10–11 times earnings with a dividend yield of about 6%, Whittaker says the stock is near a 20-year low and could benefit if the turnaround gains traction.
Whittaker also points to automotive aftermarket group Bapcor, where a CEO change is pending after Graham Wickman’s departure. He says a fresh management team could reinvigorate the business, improve margins and drive additional organic growth. Bapcor trades at around six times earnings and offers an 8% fully franked dividend yield, while improving vehicle supply could provide a tailwind for its four-wheel-drive and SUV aftermarket accessories business.